Public Calendar: March 6-12, 2022
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs
No Significant Event
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
No Significant Event
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 03/08/2022
Location: Virtual
Subject: New Era of Smarter Food Safety Update; Partnership for Food Protection 2022 National Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Officials from federal, state, local, tribal, and territorial regulatory and public health agencies
Event Date: 03/10/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 03/08/2022
Location: Virtual
Subject: America’s Blood Centers 60th Annual Meeting; FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, regulatory organizations, and other stakeholders
Event Date: 03/08/2022
Location: Virtual
Subject: 5th Annual Gene Therapy for Rare Disorders Conference; Rare Disease Gene Therapy Development: Where Has It Been and Where Is It Going?
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, regulatory organizations, and other stakeholders
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 03/11/2022
Location: Virtual
Subject: Cardiovascular Disease Prevention
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Kalin Stovall, Laura Cobb, Marci Nielsen, Nicole Ide, Tom Frieden (Resolve to Save Lives);
Event Date: 03/11/2022
Location: Virtual
Subject: Check In on Food Issues
FDA Participant/Group: KARI BARRETT;
Non FDA Participant/Group: Leslie Sarasin (Food Marketing Institute);
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 03/09/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MARGARET OELLER; WILLIAM FLYNN; ANNA O'BRIEN; ANTONIA MONIQUE SENNETT; MATTHEW LUCIA; CRYSTAL GROESBECK; AMY OMER;
Non FDA Participant/Group: Representatives of the American Sheep Industry Association (ASIA)
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event